Porsolt S.A.S. For the last 25 years our company has established itself as world leader in Preclinical Pharmacology for the Global Pharmaceutical and Biotech Industry. Following the global financial crisis in 2009, the Pharmaceutical Industry has accelerated its need to identify and advance its best preclinical drug candidates. To achieve this, outsourcing has become a core strategy for our clients which include the major Pharmaceutical Companies and a multitude of Biotechnology Companies. By combining our core values of personalised customer service with flexibility and scientific innovation we strive to provide a quality of service superior to our competitors. This customer service has been coupled with new strategic initiatives in 2010 and 2011; these include a laboratory expansion in both the USA and Europe, completed in the last quarter of 2010. Our cross-species platform of non-GLP/GLP efficacy and safety models, has positioned the company for future growth driven by the needs of our clients.